Chromatin Immunoprecipitation-Based Screen To Identify Functional Genomic Binding Sites for Sequence-Specific Transactivators
- 15 November 2005
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 25 (22) , 10148-10158
- https://doi.org/10.1128/mcb.25.22.10148-10158.2005
Abstract
In various human diseases, altered gene expression patterns are often the result of deregulated gene-specific transcription factor activity. To further understand disease on a molecular basis, the comprehensive analysis of transcription factor signaling networks is required. We developed an experimental approach, combining chromatin immunoprecipitation (ChIP) with a yeast-based assay, to screen the genome for transcription factor binding sites that link to transcriptionally regulated target genes. We used the tumor suppressor p53 to demonstrate the effectiveness of the method. Using primary and immortalized, nontransformed cultures of human mammary epithelial cells, we isolated over 100 genomic DNA fragments that contain novel p53 binding sites. This approach led to the identification and validation of novel p53 target genes involved in diverse signaling pathways, including growth factor signaling, protein kinase/phosphatase signaling, and RNA binding. Our results yield a more complete understanding of p53-regulated signaling pathways, and this approach could be applied to any number of transcription factors to further elucidate complex transcriptional networks.Keywords
This publication has 81 references indexed in Scilit:
- The p53 response: Emerging levels of co-factor complexityBiochemical and Biophysical Research Communications, 2005
- Post-translational modification of p53 in tumorigenesisNature Reviews Cancer, 2004
- The ubiquitin ligase COP1 is a critical negative regulator of p53Nature, 2004
- Complete sequencing and characterization of 21,243 full-length human cDNAsNature Genetics, 2003
- Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stressesThe EMBO Journal, 2003
- Disruption of p53 in human cancer cells alters the responses to therapeutic agentsJournal of Clinical Investigation, 1999
- In vivo evidence for binding of p53 to consensus binding sites in the p21 and GADD45 genes in response to ionizing radiationOncogene, 1997
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- p53 tagged sites from human genomic DNAHuman Molecular Genetics, 1994